Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.74 USD | +3.57% | -5.95% | -22.67% |
13/05 | Oppenheimer Adjusts Vor Biopharma Price Target to $10 From $15, Maintains Outperform Rating | MT |
09/05 | Vor Biopharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |